Federico Enrique Garcia Cipriano
Federico Enrique Garcia Cipriano has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Ricardo Mingarini Terra
Thoracic Surgery Division, Instituto do Coracao, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil
5 shared publications - Fabio May Da Silva
Department of Surgery, Universidade Federal de Santa Catarina (UFSC), Rua Professora Maria Flora Pausewang, Trindade , Florianópolis 88036-800, SC
4 shared publications - Jefferson Luiz Gross
AC Camargo Hospital
4 shared publications - Leticia Leone Lauricella
Universidade de São Paulo, Brasil
4 shared publications - Paulo Manuel Pêgo-Fernandes
Universidade de São Paulo
4 shared publications - Alexandre Todorovic Fabro
Department of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil
3 shared publications
Latest Publications
- 25 January 2026
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 68 (2)
Lymph Node Upstaging in Robotic, Video-Assisted Thoracic Surgery, and Open Lung Resections: A Matched Analysis From the Brazilian Lung Cancer Registry
Objectives: To evaluate if the use of robotic technique (RATS) was able to achieve a better lymph node staging when compared with video-assisted (VATS) and open techniques for lung resections for treatment of non-small cell lung cancer. Methods: We used data from the Brazilian Lung Cancer Registry to retrospectively analyse 1376 patients submitted to lung resections for non-small cell lung cancer with curative intention. A propensity score matching analysis was performed to create groups with comparable baseline characteristics in a pairwise fashion (open vs RATS and VATS vs RATS). The primary endpoint was nodal upstaging. Results: After propensity score matching, 165 patients in the open group were compared with 165 in the RATS group. The rate of overall upstaging was higher in the open but not statistically significant when compared with RATS (open 22.4% vs RATS 15.2%; P = .09). Total lymph node count was similar for both groups (open 10; interquartile range [IQR] 5-17 vs RATS 11; IQR 8-17), P = .054). In the other comparison, 279 patients in the VATS group were compared with 279 patients in the RATS group. The rate of overall upstaging was the same in both groups (VATS 11.1% vs RATS 11.1%; P = 1). RATS had a higher number of lymph nodes harvested (VATS 9; IQR 6-13 vs RATS 10; IQR 7-15, P < .001). Conclusions: RATS had a similar upstaging rate when compared with both VATS and open techniques.
- 25 January 2026
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 68 (2)
Lymph Node Upstaging in Robotic, Video-Assisted Thoracic Surgery, and Open Lung Resections: A Matched Analysis From the Brazilian Lung Cancer Registry
Objectives: To evaluate if the use of robotic technique (RATS) was able to achieve a better lymph node staging when compared with video-assisted (VATS) and open techniques for lung resections for treatment of non-small cell lung cancer. Methods: We used data from the Brazilian Lung Cancer Registry to retrospectively analyse 1376 patients submitted to lung resections for non-small cell lung cancer with curative intention. A propensity score matching analysis was performed to create groups with comparable baseline characteristics in a pairwise fashion (open vs RATS and VATS vs RATS). The primary endpoint was nodal upstaging. Results: After propensity score matching, 165 patients in the open group were compared with 165 in the RATS group. The rate of overall upstaging was higher in the open but not statistically significant when compared with RATS (open 22.4% vs RATS 15.2%; P = .09). Total lymph node count was similar for both groups (open 10; interquartile range [IQR] 5-17 vs RATS 11; IQR 8-17), P = .054). In the other comparison, 279 patients in the VATS group were compared with 279 patients in the RATS group. The rate of overall upstaging was the same in both groups (VATS 11.1% vs RATS 11.1%; P = 1). RATS had a higher number of lymph nodes harvested (VATS 9; IQR 6-13 vs RATS 10; IQR 7-15, P < .001). Conclusions: RATS had a similar upstaging rate when compared with both VATS and open techniques.
- Open Access
- 6 October 2025
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 40 (10)
Understanding Barriers to Adjuvant Therapy in Resected Non-small Cell Lung Cancer: A Multicenter Analysis
Objectives: To investigate variables associated to not receiving adjuvant therapy in patients with resected pathological IB-IIIA non-small-cell lung cancer (NSCLC) from a national registry. Methods: Patients who had lung resections were analysed retrospectively for stages IB-III from 2009-2023, sourced from a multicenter registry. Uni/multivariable logistic regression was performed, and a predictive tool was created to predict adjuvant therapy probability and cut-off values were determined through receiver-operating characteristic curve (ROC). The model’s discrimination, performance, and fit were evaluated using area under the ROC curve (AUC-ROC), sensitivity/specificity, and Hosmer-Lemeshow test, respectively. Results: Of the 427 patients analysed, the mean age was 65.4 years, and 83.1% were treated under public insurance. Precisely, 38.4% of patients received adjuvant chemotherapy after surgery. Multivariable analysis identified older age (odds ratio [OR] = 1.06, P < 0.001), histological subtype (OR = 21.3, P < 0.001), public insurance (OR = 2.65, P = 0.006), stage I-B (OR = 8.10, P = 0.002), and negative lymph node status (OR = 3.34, P < 0.001) as independent factors associated with not receiving adjuvant therapy. Using the final equation, a calculated probability > 42.5% categorizes a patient for exclusive surgical intervention. The model’s performance yielded an AUC of 0.833, with a sensitivity of 90.2%. The Hosmer-Lemeshow test resulted in a P ≥ 0.05. Conclusions: Underutilization of adjuvant therapy in NSCLC is influenced by age, insurance type, and pathological factors. Public insurance status indicates healthcare access but does not fully capture social disparities. The absence of race, income, and geographic data limits broader analysis. Our model identifies patients at risk of treatment omission, aiding targeted interventions.
- 6 October 2025
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 40 (10)
Open AccessUnderstanding Barriers to Adjuvant Therapy in Resected Non-small Cell Lung Cancer: A Multicenter Analysis
Objectives: To investigate variables associated to not receiving adjuvant therapy in patients with resected pathological IB-IIIA non-small-cell lung cancer (NSCLC) from a national registry. Methods: Patients who had lung resections were analysed retrospectively for stages IB-III from 2009-2023, sourced from a multicenter registry. Uni/multivariable logistic regression was performed, and a predictive tool was created to predict adjuvant therapy probability and cut-off values were determined through receiver-operating characteristic curve (ROC). The model’s discrimination, performance, and fit were evaluated using area under the ROC curve (AUC-ROC), sensitivity/specificity, and Hosmer-Lemeshow test, respectively. Results: Of the 427 patients analysed, the mean age was 65.4 years, and 83.1% were treated under public insurance. Precisely, 38.4% of patients received adjuvant chemotherapy after surgery. Multivariable analysis identified older age (odds ratio [OR] = 1.06, P < 0.001), histological subtype (OR = 21.3, P < 0.001), public insurance (OR = 2.65, P = 0.006), stage I-B (OR = 8.10, P = 0.002), and negative lymph node status (OR = 3.34, P < 0.001) as independent factors associated with not receiving adjuvant therapy. Using the final equation, a calculated probability > 42.5% categorizes a patient for exclusive surgical intervention. The model’s performance yielded an AUC of 0.833, with a sensitivity of 90.2%. The Hosmer-Lemeshow test resulted in a P ≥ 0.05. Conclusions: Underutilization of adjuvant therapy in NSCLC is influenced by age, insurance type, and pathological factors. Public insurance status indicates healthcare access but does not fully capture social disparities. The absence of race, income, and geographic data limits broader analysis. Our model identifies patients at risk of treatment omission, aiding targeted interventions.
- Open Access
- 17 July 2025
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 46 (6) , 1464-1470
Combined Extracorporeal Carbon Dioxide Removal (ECCO2R) With Renal Replacement Therapy and Blood Purification in a Severe Inhalation Injury Patient—Case Report
Severe burns complicated by inhalational trauma represent a clinically challenging combination, particularly in elderly patients with multiple comorbidities. The following case report highlights the successful management of an elderly patient with second-degree burns and inhalational trauma following a residential fire. Given the severity of the clinical presentation, a combined approach incorporating extracorporeal CO2 removal (ECCO2R) to allow for early protective ventilation, continuous renal replacement therapy for precise hydroelectrolytic management, and blood purification for early immunomodulation was implemented. The case report describes a 75-year-old male patient with multiple comorbidities, including obesity and Parkinson’s disease, who presented with severe burns and inhalational injury following a residential fire. The patient was admitted to the intensive care unit (ICU) with severe respiratory compromise, requiring invasive mechanical ventilation and hemodynamic support. After a multidisciplinary assessment, preemptive installation of ECCO2R combined with renal replacement therapy and blood purification filter was decided upon. Multi-organ extracorporeal support was maintained for 96 h, resulting in substantial improvement in respiratory and hemodynamic functions. After discontinuation of extracorporeal support, the patient’s renal function fully recovered, obviating the need for subsequent hemodialysis. The patient was weaned off mechanical ventilation and discharged from the ICU after a 14-day stay. He is currently under outpatient follow-up, demonstrating favorable recovery. This report underscores the efficacy and safety of the combined approach of ECCO2R, renal replacement therapy, and blood purification in patients with severe inhalational injury and burns. Early intervention showed a positive impact on the patient’s clinical progression, highlighting the importance of multidisciplinary evaluation and integrated management in complex cases. Although further studies are necessary to validate these findings, this case illustrates promising potential for this therapeutic strategy in similar scenarios.
- 17 July 2025
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 46 (6) , 1464-1470
Open AccessCombined Extracorporeal Carbon Dioxide Removal (ECCO2R) With Renal Replacement Therapy and Blood Purification in a Severe Inhalation Injury Patient—Case Report
Severe burns complicated by inhalational trauma represent a clinically challenging combination, particularly in elderly patients with multiple comorbidities. The following case report highlights the successful management of an elderly patient with second-degree burns and inhalational trauma following a residential fire. Given the severity of the clinical presentation, a combined approach incorporating extracorporeal CO2 removal (ECCO2R) to allow for early protective ventilation, continuous renal replacement therapy for precise hydroelectrolytic management, and blood purification for early immunomodulation was implemented. The case report describes a 75-year-old male patient with multiple comorbidities, including obesity and Parkinson’s disease, who presented with severe burns and inhalational injury following a residential fire. The patient was admitted to the intensive care unit (ICU) with severe respiratory compromise, requiring invasive mechanical ventilation and hemodynamic support. After a multidisciplinary assessment, preemptive installation of ECCO2R combined with renal replacement therapy and blood purification filter was decided upon. Multi-organ extracorporeal support was maintained for 96 h, resulting in substantial improvement in respiratory and hemodynamic functions. After discontinuation of extracorporeal support, the patient’s renal function fully recovered, obviating the need for subsequent hemodialysis. The patient was weaned off mechanical ventilation and discharged from the ICU after a 14-day stay. He is currently under outpatient follow-up, demonstrating favorable recovery. This report underscores the efficacy and safety of the combined approach of ECCO2R, renal replacement therapy, and blood purification in patients with severe inhalational injury and burns. Early intervention showed a positive impact on the patient’s clinical progression, highlighting the importance of multidisciplinary evaluation and integrated management in complex cases. Although further studies are necessary to validate these findings, this case illustrates promising potential for this therapeutic strategy in similar scenarios.
- Open Access
- 18 September 2024
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 50 (4) , e20240226
External validation of the parsimonious EuroLung risk models: analysis of the Brazilian Lung Cancer Registry
Objective: The purpose of this study was to assess performance in the Brazilian Lung Cancer Registry Database by using the parsimonious EuroLung risk models for morbidity and mortality. Methods: The EuroLung1 and EuroLung2 models were tested and evaluated through calibration (calibration plot, Brier score, and the Hosmer-Lemeshow test) and discrimination (ROC AUCs), in a national multicenter registry of 1,031 patients undergoing anatomic lung resection. Results: The evaluation of performance in Brazilian health care facilities utilizing risk-adjustment models, specifically EuroLung1 and EuroLung2, revealed substantial miscalibration, as evidenced by calibration plots and Hosmer-Lemeshow tests in both models. In terms of calibration, EuroLung1 exhibited a calibration plot with overlapping points, characterized by a slope of 1.11 and a Brier score of 0.15; the Hosmer-Lemeshow test yielded a statistically significant p-value of 0.015; and the corresponding ROC AUC was 0.678 (95% CI: 0.636-0.721). The EuroLung2 model displayed better calibration, featuring fewer overlapping points in the calibration plot, with a slope of 1.22, with acceptable discrimination, as indicated by a ROC AUC of 0.756 (95% CI: 0.670-0.842). Both models failed to accurately predict morbidity and mortality outcomes in this specific health care context. Conclusions: Discrepancies between the EuroLung model predictions and outcomes in Brazil underscore the need for model refinement and for a probe into inefficiencies in the Brazilian health care system. (Plataforma Brasil identifier: 16424413.2.1001.0065. [https://plataformabrasil.saude.gov.br/])
- 18 September 2024
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 50 (4) , e20240226
Open AccessExternal validation of the parsimonious EuroLung risk models: analysis of the Brazilian Lung Cancer Registry
Objective: The purpose of this study was to assess performance in the Brazilian Lung Cancer Registry Database by using the parsimonious EuroLung risk models for morbidity and mortality. Methods: The EuroLung1 and EuroLung2 models were tested and evaluated through calibration (calibration plot, Brier score, and the Hosmer-Lemeshow test) and discrimination (ROC AUCs), in a national multicenter registry of 1,031 patients undergoing anatomic lung resection. Results: The evaluation of performance in Brazilian health care facilities utilizing risk-adjustment models, specifically EuroLung1 and EuroLung2, revealed substantial miscalibration, as evidenced by calibration plots and Hosmer-Lemeshow tests in both models. In terms of calibration, EuroLung1 exhibited a calibration plot with overlapping points, characterized by a slope of 1.11 and a Brier score of 0.15; the Hosmer-Lemeshow test yielded a statistically significant p-value of 0.015; and the corresponding ROC AUC was 0.678 (95% CI: 0.636-0.721). The EuroLung2 model displayed better calibration, featuring fewer overlapping points in the calibration plot, with a slope of 1.22, with acceptable discrimination, as indicated by a ROC AUC of 0.756 (95% CI: 0.670-0.842). Both models failed to accurately predict morbidity and mortality outcomes in this specific health care context. Conclusions: Discrepancies between the EuroLung model predictions and outcomes in Brazil underscore the need for model refinement and for a probe into inefficiencies in the Brazilian health care system. (Plataforma Brasil identifier: 16424413.2.1001.0065. [https://plataformabrasil.saude.gov.br/])
- Open Access
- 24 June 2024
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 22 (Suppl 1)
Underutilization of adjuvant therapy in resected IB-III non-small-cell lung cancer risk model - analysis from the Brazilian registry of lung cancer
Category: Thoracic Oncology Introduction: Despite the proven survival benefits of adjuvant systemic therapy (AT) in resected non-small-cell lung cancer (NSCLC), its underutilization remains a concern.(–) Objecitve: This study aims to explore the extent to which socioeconomic disparities influence AT underutilization. Methods: Data from the Brazilian Registry of Lung Cancer (2009-2023), was queried for patients with complete surgical resected stage IB-III and stratified based on AT delivery. Demographic, clinical, and pathological variables were evaluated. Logistic regression model was performed. The model’s
- 24 June 2024
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 22 (Suppl 1)
Open AccessUnderutilization of adjuvant therapy in resected IB-III non-small-cell lung cancer risk model - analysis from the Brazilian registry of lung cancer
Category: Thoracic Oncology Introduction: Despite the proven survival benefits of adjuvant systemic therapy (AT) in resected non-small-cell lung cancer (NSCLC), its underutilization remains a concern.(–) Objecitve: This study aims to explore the extent to which socioeconomic disparities influence AT underutilization. Methods: Data from the Brazilian Registry of Lung Cancer (2009-2023), was queried for patients with complete surgical resected stage IB-III and stratified based on AT delivery. Demographic, clinical, and pathological variables were evaluated. Logistic regression model was performed. The model’s
- Open Access
- 24 June 2024
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 22 (Suppl 1)
Development of a Nomogram for Predicting Survival in Early-Stage Non-Small Cell Lung Cancer: Insights from the Brazilian Lung Cancer Registry
Category: Thoracic Oncology Introduction: The prognostic evaluation of early-stage non-small cell lung cancer (NSCLC) remains critical for optimizing treatment strategies and improving patient outcomes.(–) Objective: This study aims to delineate the pivotal predictors affecting survival rates among early-stage NSCLC patients, leveraging data from the Brazilian Lung Cancer Registry. Methods: This study retrospectively analyzed data from the Brazilian Lung Cancer Registry, encompassing 2,045 patients who underwent surgical treatment for lung cancer across 14 institutions in five Brazilian states. The registry is
- 24 June 2024
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 22 (Suppl 1)
Open AccessDevelopment of a Nomogram for Predicting Survival in Early-Stage Non-Small Cell Lung Cancer: Insights from the Brazilian Lung Cancer Registry
Category: Thoracic Oncology Introduction: The prognostic evaluation of early-stage non-small cell lung cancer (NSCLC) remains critical for optimizing treatment strategies and improving patient outcomes.(–) Objective: This study aims to delineate the pivotal predictors affecting survival rates among early-stage NSCLC patients, leveraging data from the Brazilian Lung Cancer Registry. Methods: This study retrospectively analyzed data from the Brazilian Lung Cancer Registry, encompassing 2,045 patients who underwent surgical treatment for lung cancer across 14 institutions in five Brazilian states. The registry is
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Radiologia Brasileira
- Vol. 57, e20240033
Look-Locker T1 relaxometry and high-resolution T2 in the evaluation of lung lesions: a single-center prospective study
Objective: To explore the feasibility of two magnetic resonance imaging (MRI) sequences—high-resolution T2-weighted (HR T2) and Look-Locker T1 (LL T1) relaxometry—for the investigation focal lung lesions (FLLs). As a secondary objective, we analyzed the diagnostic accuracy of these sequences. Materials and Methods: This was a prospective observational study involving 39 subjects with FLLs scanned in a 1.5-T MRI system with LL T1 relaxometry and HR T2 sequences focused on the FLL region, in addition to a conventional protocol. All images were evaluated by two radiologists, working independently, who were blinded to other findings. Results: Most of the examinations (31 of the LL T1 relaxometry sequences and 36 of the HR T2 sequences) were of adequate diagnostic quality. Nondiagnostic examinations were considered so mainly because of limited coverage of the sequences. Of the FLLs studied, 19 were malignant, 17 were benign, and three were excluded from the accuracy analysis because there was no definitive diagnosis. Although LL T1 relaxometry could not distinguish between benign and malignant lesions, the signal intensity at its first inversion time (160 ms) differed between the two groups. The HR T2 sequence was considered the best sequence for assessing specific morphological characteristics, especially pseudocavities and pleural tags. We found that MRI showed better accuracy than did computed tomography (86% vs. 74%). Conclusion: Both MRI sequences are feasible for the evaluation of FLLs. Images at 160 ms of the LL T1 relaxometry sequence helped distinguish between benign and malignant lesions, and the HR T2 sequence was considered the best sequence for evaluating specific morphological characteristics.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Radiologia Brasileira
- Vol. 57, e20240033
Open AccessLook-Locker T1 relaxometry and high-resolution T2 in the evaluation of lung lesions: a single-center prospective study
Objective: To explore the feasibility of two magnetic resonance imaging (MRI) sequences—high-resolution T2-weighted (HR T2) and Look-Locker T1 (LL T1) relaxometry—for the investigation focal lung lesions (FLLs). As a secondary objective, we analyzed the diagnostic accuracy of these sequences. Materials and Methods: This was a prospective observational study involving 39 subjects with FLLs scanned in a 1.5-T MRI system with LL T1 relaxometry and HR T2 sequences focused on the FLL region, in addition to a conventional protocol. All images were evaluated by two radiologists, working independently, who were blinded to other findings. Results: Most of the examinations (31 of the LL T1 relaxometry sequences and 36 of the HR T2 sequences) were of adequate diagnostic quality. Nondiagnostic examinations were considered so mainly because of limited coverage of the sequences. Of the FLLs studied, 19 were malignant, 17 were benign, and three were excluded from the accuracy analysis because there was no definitive diagnosis. Although LL T1 relaxometry could not distinguish between benign and malignant lesions, the signal intensity at its first inversion time (160 ms) differed between the two groups. The HR T2 sequence was considered the best sequence for assessing specific morphological characteristics, especially pseudocavities and pleural tags. We found that MRI showed better accuracy than did computed tomography (86% vs. 74%). Conclusion: Both MRI sequences are feasible for the evaluation of FLLs. Images at 160 ms of the LL T1 relaxometry sequence helped distinguish between benign and malignant lesions, and the HR T2 sequence was considered the best sequence for evaluating specific morphological characteristics.
- 1 June 2021
- Published by Elsevier in Clinical Imaging
- Vol. 74, 27-30
Quantifying intratumor heterogeneity of lung neoplasms with radiomics
- 1 June 2021
- Published by Elsevier in Clinical Imaging
- Vol. 74, 27-30
Quantifying intratumor heterogeneity of lung neoplasms with radiomics
- Open Access
- 1 April 2021
- Published by FapUNIFESP (SciELO) in Radiologia Brasileira
- Vol. 54 (2) , 87-93
Radiomic analysis of lung cancer for the assessment of patient prognosis and intratumor heterogeneity
Objective: To determine whether the radiomic features of lung lesions on computed tomography correlate with overall survival in lung cancer patients. Materials and Methods: This was a retrospective study involving 101 consecutive patients with malignant neoplasms confirmed by biopsy or surgery. On computed tomography images, the lesions were submitted to semi-automated segmentation and were characterized on the basis of 2,465 radiomic variables. The prognostic assessment was based on Kaplan-Meier analysis and log-rank tests, according to the median value of the radiomic variables. Results: Of the 101 patients evaluated, 28 died (16 dying from lung cancer), and 73 were censored, with a mean overall survival time of 1,819.4 days (95% confidence interval [95% CI]: 1,481.2-2,157.5). One radiomic feature (the mean of the Fourier transform) presented a difference on Kaplan-Meier curves (p < 0.05). A high-risk group of patients was identified on the basis of high values for the mean of the Fourier transform. In that group, the mean survival time was 1,465.4 days (95% CI: 985.2-1,945.6), with a hazard ratio of 2.12 (95% CI: 1.01-4.48). We also identified a low-risk group, in which the mean of the Fourier transform was low (mean survival time of 2,164.8 days; 95% CI: 1,745.4-2,584.1). Conclusion: A radiomic signature based on the Fourier transform correlates with overall survival, representing a prognostic biomarker for risk stratification in patients with lung cancer.
- 1 April 2021
- Published by FapUNIFESP (SciELO) in Radiologia Brasileira
- Vol. 54 (2) , 87-93
Open AccessRadiomic analysis of lung cancer for the assessment of patient prognosis and intratumor heterogeneity
Objective: To determine whether the radiomic features of lung lesions on computed tomography correlate with overall survival in lung cancer patients. Materials and Methods: This was a retrospective study involving 101 consecutive patients with malignant neoplasms confirmed by biopsy or surgery. On computed tomography images, the lesions were submitted to semi-automated segmentation and were characterized on the basis of 2,465 radiomic variables. The prognostic assessment was based on Kaplan-Meier analysis and log-rank tests, according to the median value of the radiomic variables. Results: Of the 101 patients evaluated, 28 died (16 dying from lung cancer), and 73 were censored, with a mean overall survival time of 1,819.4 days (95% confidence interval [95% CI]: 1,481.2-2,157.5). One radiomic feature (the mean of the Fourier transform) presented a difference on Kaplan-Meier curves (p < 0.05). A high-risk group of patients was identified on the basis of high values for the mean of the Fourier transform. In that group, the mean survival time was 1,465.4 days (95% CI: 985.2-1,945.6), with a hazard ratio of 2.12 (95% CI: 1.01-4.48). We also identified a low-risk group, in which the mean of the Fourier transform was low (mean survival time of 2,164.8 days; 95% CI: 1,745.4-2,584.1). Conclusion: A radiomic signature based on the Fourier transform correlates with overall survival, representing a prognostic biomarker for risk stratification in patients with lung cancer.